ARCHIVES

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

This article is from The Cancer Letter archive.

Vol. 30 No. 33 | August 13, 2004

Download PDF Visit The Full Archive

Related Articles

Inspector General’s chronology Of Events In Gallo Research

July 1, 1994

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

November 15, 2013

Senate Committee Ok’s $1.9 Billion Budget For NCI, Same As House Appropriation

July 29, 1994

Funding Opportunities Listed.

January 14, 2005

Moyniham Bill Will Direct HHS to Exempt Centers Recognized By NCI From Prospective Payment System

August 15, 1986

Increased Lung Cancer Risk After Hodgkin’s Treatment

February 22, 2002